Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-retinal arterial fibrinolysis for central retinal artery occlusion
jRCTs031180441Completed
- Start
- Nov 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of tissue-plasminogen activator in central retinal artery occlusion (CRAO). Primary endpoint: Visual acuity at 24 weeks after surgery. Started Nov 2015; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
central retinal artery occlusion (CRAO)
Beyond the preview
Go deeper on jRCTs031180441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180441.